about
A shared-care model of obesity treatment for 3-10 year old children: protocol for the HopSCOTCH randomised controlled trial.The LIFE child study: a life course approach to disease and health.An assessment of pancreatic endocrine function and insulin sensitivity in patients with transient neonatal diabetes in remissionIGFBP-2 - taking the lead in growth, metabolism and cancerCharacterisation of morbidity in a UK, hospital based, obesity clinic.Childhood nutrition in predicting metabolic syndrome in adults: the cardiovascular risk in Young Finns StudyShared care obesity management in 3-10 year old children: 12 month outcomes of HopSCOTCH randomised trial.Combined effects of child and adult elevated blood pressure on subclinical atherosclerosis: the International Childhood Cardiovascular Cohort Consortium.IGFBP-2: The dark horse in metabolism and cancer.Dietary monounsaturated fat in early life regulates IGFBP2: implications for fat mass accretion and insulin sensitivity.Youth overweight and metabolic disturbances in predicting carotid intima-media thickness, type 2 diabetes, and metabolic syndrome in adulthood: the Cardiovascular Risk in Young Finns study.Higher maternal body mass index is associated with an increased risk for later type 2 diabetes in offspring.Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy.Precocious puberty in Turner syndrome.Early childhood hospitalisation with infection and subclinical atherosclerosis in adulthood: the Cardiovascular Risk in Young Finns Study.Adult dyslipidemia prediction is improved by repeated measurements in childhood and young adulthood. The Cardiovascular Risk in Young Finns Study.Childhood 25-OH vitamin D levels and carotid intima-media thickness in adulthood: the cardiovascular risk in young Finns study.Natural BMI reductions and overestimation of obesity trial effectiveness.Insulin and BMI as predictors of adult type 2 diabetes mellitus.New directions in childhood obesity research: how a comprehensive biorepository will allow better prediction of outcomes.Site-specific differences of insulin action in adipose tissue derived from normal prepubertal children.An observational study of type 2 diabetes within a large Australian tertiary hospital pediatric diabetes service.Treatment of childhood obesity by retraining eating behaviour: randomised controlled trial.Monitoring height and weight: findings from a developmental paediatric service.Reactive pituitary hyperplasia associated with paediatric primary hypothyroidism.A diagnosis of the metabolic syndrome in youth that resolves by adult life is associated with a normalization of high carotid intima-media thickness and type 2 diabetes mellitus risk: the Bogalusa heart and cardiovascular risk in young Finns studiesCharacterization of differentiated subcutaneous and visceral adipose tissue from children: the influences of TNF-alpha and IGF-I.How training affects Australian paediatricians' management of obesity.Age-specific stabilization in obesity prevalence in German children: a cross-sectional study from 1999 to 2008.Obesity: predicting risk of later obesity from the first day of life.Elevated glucose concentrations during an oral glucose tolerance test are associated with the presence of metabolic syndrome in childhood obesity.Fasting nonesterified fatty acid profiles in childhood and their relationship with adiposity, insulin sensitivity, and lipid levels.Which factors are associated with a successful outcome in a weight management programme for obese children?Normalizing eating behavior reduces body weight and improves gastrointestinal hormonal secretion in obese adolescents.Depot-specific effects of fatty acids on lipid accumulation in children's adipocytes.Fatty acid-induced defects in insulin signalling, in myotubes derived from children, are related to ceramide production from palmitate rather than the accumulation of intramyocellular lipid.Mature subcutaneous and visceral adipocyte concentrations of adiponectin are highly correlated in prepubertal children and inversely related to body mass index standard deviation score.Childhood adiposity, adult adiposity, and cardiovascular risk factors.Leptin enhances insulin sensitivity by direct and sympathetic nervous system regulation of muscle IGFBP-2 expression: evidence from nonrodent models.IGFBP-2 inhibits adipogenesis and lipogenesis in human visceral, but not subcutaneous, adipocytes.
P50
Q34210683-7B9D89F7-67AC-49A0-978C-5D9092660775Q34488719-53B5F4DE-9D16-4C3C-9B41-635A65967B0FQ35295001-CDC5B51F-D680-49D1-B72E-2689CC2A71DCQ35690628-9CECA305-78D5-4A32-8AB6-9FD63C9E5C7BQ36152839-D34F586A-31C6-4D07-9750-05659F22DCD6Q36181400-158AEC10-89F8-4413-9155-44F67A7F19D3Q36916432-6FEC28E5-002F-476A-8DFC-FAA63BD4B3ACQ37420284-B812870B-8BC2-499D-9A9F-55465DA993FDQ38301814-BE52A5C8-F592-4625-B583-0EC873EA5F63Q38336392-2E61960F-6A1B-4C7C-81F7-B933562CF86AQ39208050-F0037693-30FD-47F3-BF30-F4B6BA14BA8BQ39499384-752B7125-2646-4761-8282-1295FA71AC40Q39833131-9C44CB3C-F3F2-4F17-B84D-60E409EA7492Q40165885-12903C99-AA3C-4DFC-9B59-A5A7E44114BBQ41344246-B68713B4-F660-45E1-9BFC-270339161BCEQ41435947-C2CD9B92-3B9B-4513-BA2B-76A18E6D0D27Q41454790-6506ABE4-5EB8-4309-A97A-4623FC6F1F8AQ41589662-B44FBCDF-9A23-4BA4-8BEB-090D1F80DDBEQ41656099-4707C45A-1502-4833-BC75-B35F40D1DDFDQ42357156-2A3333E3-EC7C-47C7-A145-C70A8B047543Q42479375-04C79B1F-888E-412E-BF8F-0B041E9AFDAEQ43118746-F1098FE7-8E54-451A-A0E2-53930A868D56Q43201839-6BCF8829-F17A-42D9-8952-18E3C98B2981Q43759731-975DFA68-A2CB-41EC-B06D-DA92A23A7E8AQ44229081-4670C677-01F6-4BAD-A7A3-375FDA945777Q44231265-C445BCE5-90EC-4C69-AC89-7BCBCD93F25AQ45110883-628487BB-2C49-4BD7-A873-493F8A7E79E2Q45775336-3CA9AD85-9961-4147-B72A-0F52115252BDQ45908321-294F9546-055C-49A9-842A-FE38295F0D18Q46612638-08C012B0-3225-4B7B-8C54-5915EF861678Q46728076-CD7035C6-5FB7-42FE-A147-82A2EF9158C4Q46869029-2F99DC24-8CFD-4F49-8F81-8253F03D3BFFQ47287043-C0195FFE-2E3B-4E91-89F4-0981438C91DFQ47338515-07B4A7F8-61D7-41F0-8F68-67AA032F327DQ50687456-121FDFA3-A879-4FD5-BF3F-7EA1062807D2Q50708945-28F6755F-DC61-4A35-9BD1-C160F3E96B9FQ51508685-12E5C641-019C-4BBD-BE6E-BC3F97FD6D1AQ53141828-F4727B1E-A93E-4ED7-82D7-8ACA3BDA8757Q54216945-CDE2E0B1-D3A1-48A4-BBCC-C03074021410Q54311672-600CBCD6-6C4E-49E5-BA81-3D97497B47BE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Matthew A. Sabin
@ast
Matthew A. Sabin
@en
Matthew A. Sabin
@es
Matthew A. Sabin
@nl
Matthew A. Sabin
@sl
type
label
Matthew A. Sabin
@ast
Matthew A. Sabin
@en
Matthew A. Sabin
@es
Matthew A. Sabin
@nl
Matthew A. Sabin
@sl
altLabel
Matt Sabin
@en
prefLabel
Matthew A. Sabin
@ast
Matthew A. Sabin
@en
Matthew A. Sabin
@es
Matthew A. Sabin
@nl
Matthew A. Sabin
@sl
P108
P1053
B-3539-2012
P106
P1153
7004975499
P21
P31
P3829
P496
0000-0002-1828-7404